Newsletter Subject

Novel 'Off the Shelf' CAR-T Product Shows Promise in Myeloma

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, Feb 2, 2023 11:51 PM

Email Preheader Text

Daily Headlines Thursday, February 02, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLI

[MEDPAGE TODAY]( Daily Headlines Thursday, February 02, 2023 Today's Top Stories for {NAME} [ONCOLOGY/HEMATOLOGY]( [Novel 'Off the Shelf' CAR-T Product Shows Promise in Myeloma]( [PUBLIC HEALTH & POLICY]( [Family and Medical Leave Act Has Benefited Workers and Businesses, Biden Says]( [OPHTHALMOLOGY]( [CDC Sounds Alarm on Eye Drops Linked With Drug-Resistant Infection]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Novel Approaches for the Treatment of Acute Myeloid Leukemia]( [NEPHROLOGY]( [Chilling Donors Not as Good as Machine Perfusion for Kidney Transplant]( [PULMONOLOGY]( [Hospital Frailty Risk Score Not Up to Snuff for Patients With COPD Exacerbation]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [SPECIAL REPORTS]( [Bowden's Defamation Suit Against Houston Methodist Tossed]( CME SPOTLIGHT [Novel Immunotherapeutic Approaches in Relapsed/Refractory Multiple Myeloma]( [SPECIAL REPORTS]( [Baby's Death During Nursing Strike Probed; Nurse Killer Guilty; Doc Gets 16.5 Years]( [RHEUMATOLOGY]( [Rheumatoid Factor and ACPA, Meet Potential New Partners for RA Diagnosis]( [MEETING COVERAGE]( [Two Biliary Tract Cancer Trials Took Center Stage at ASCO GI]( CME SPOTLIGHT [Evidence-Based Strategies for Integrating CAR T-Cell Therapy Into Non-Hodgkin Lymphoma Care]( [INFECTIOUS DISEASE]( [VA's Formulary May Have Curbed Misuse of Ivermectin for COVID-19]( [DERMATOLOGY]( [Targeting Specific Lipid Metabolic Pathway Linked to Reduced Psoriasis Risk]( [NEPHROLOGY]( [First Oral Treatment for CKD Anemia OK'd for Patients on Dialysis]( CME SPOTLIGHT [Treatment and Management of Patients with HER2+ Advanced/Metastatic Breast Cancer]( [INFECTIOUS DISEASE]( [What Changes When the COVID Emergency Ends in May?]( [MEDICAL JOURNEYS]( [Managing Advanced Cardiomyopathy]( [MEDICAL JOURNEYS]( [For Your Patients: Planning Ahead With End-Stage Cardiomyopathy]( CME SPOTLIGHT [Emerging Evidence in the Treatment of Chronic Lymphocytic Leukemia]( CME SPOTLIGHT [Transforming HR+/HER2- Breast Cancer Care: Real-world Patient and Provider Perspectives]( # Weekly Survey [Annual COVID-19 Boosters?]( The FDA [is proposing]( annually updated COVID booster shots for all Americans each fall, much like the flu shot[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-02-02&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

31/05/2024

Sent On

31/05/2024

Sent On

31/05/2024

Sent On

31/05/2024

Sent On

30/05/2024

Sent On

30/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.